CompoAtlas

Amla

Natural health product licensed in Canada

Other names
Amlaki, Seyamo Amla
Licence holder
Seyamo Inc.
NPN or DIN-HM
80123502
Status
Active licence
Licence date
10 March 2023
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Phyllanthus emblica

Source : Phyllanthus emblica - fruit

Extract : Matériel brut sec

Extraction ratio : 4:1

Dry plant equivalent : 2 g

500 mgNot calculated

Non-medicinal ingredients

Hypromellose

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 yearsminimum: 2 Capsule ; maximum: 3 Capsule1 day

Uses authorised in Canada

Text supplied in English because no French text is available.

Source of/Provides antioxidants. Traditionally used in Ayurveda as Rasayana (rejuvenative tonic). Traditionally used in Ayurveda as a digestive tonic to increase appetite and aid in digestion (stomachic). Traditionally used in Ayurveda as a laxative for the relief of occasional constipation. Traditionally used in Ayurveda to help relieve symptoms such as heartburn and indigestion associated with Amlapitta (hyperacidity/dyspepsia).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80123502

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line